Company
Headquarters: Naples, Italy
Employees: 66
CEO: Mr. Antonio Scala
€55.4 Million
EUR as of Jan. 1, 2025
US$57.7 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Shedir Pharma Group S.p.A., through its subsidiaries, engages in the medical and pharmaceutical business in Italy. It engages in the research, development, and marketing of nutraceuticals, cosmetics, and medical devices. The company offers products for andrological, cardiovascular, dermatological, hematological, energy, gastrointestinal, gynecological, metabolic, neurological, dental, ophthalmic, osteoarticular, ontological, respiratory, and trichological disorders. The company was founded in 2008 and is based in Naples, Italy.
Shedir Pharma Group S.p.A. has the following listings and related stock indices.
Stock: MTA: SHE